John Harrington
Keine laufenden Positionen mehr
Vermögen: 163 $ am 31.03.2024
Profil
John J.
Harrington is the founder of Athersys, Inc. which was founded in 1995.
He held the title of Director, Chief Scientific Officer & Executive VP from 1995 to 2022.
He also founded Athersys, Inc. in 2007.
Dr. Harrington's former job was as Chief Scientific Officer & EVP at BTHC VI, Inc. Dr. Harrington received a doctorate degree from Stanford University and an undergraduate degree from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATHERSYS, INC.
0,04% | 14.08.2023 | 27 169 ( 0,04% ) | 163 $ | 31.03.2024 |
Ehemalige bekannte Positionen von John Harrington
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Founder | 16.06.2022 |
| BTHC VI, Inc. | Chief Tech/Sci/R&D Officer | 06.09.2007 |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Founder | 08.06.2007 |
Ausbildung von John Harrington
| Stanford University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Athersys, Inc. /Old/
Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Health Technology |
| BTHC VI, Inc. | Finance |
